Focus on MicroRNAs as Biomarker in Pediatric Diseases

Curr Pharm Des. 2021;27(6):826-832. doi: 10.2174/1381612826666201021125512.

Abstract

Background: MiRNAs are a class of small non-coding RNAs that are involved in the post-transcriptional regulation of gene expression. MiRNAs are considered a class of epigenetic biomarkers. These biomarkers can investigate disease at different stages: diagnosis, therapy or clinical follow-up.

Objective: The aim of this paper is to highlight the innovative use of miRNAs in several childhood diseases.

Methods: We conducted a literature review to search the usage of miRNAs in pediatric clinical routine or experimental trials.

Results: We found a possible key role of miRNAs in different pediatric illnesses (metabolic alterations, coagulation defects, cancer).

Conclusion: The modest literature production denotes that further investigation is needed to assess and validate the promising role of miRNAs as non-invasive biomarkers in pediatric disorders.

Keywords: MicroRNAs; autism; biomarker; cancer; children; hemophilia; metabolic syndrome; pediatrics.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biomarkers, Tumor / genetics
  • Child
  • Gene Expression Regulation
  • Humans
  • MicroRNAs* / genetics
  • Neoplasms* / diagnosis
  • Neoplasms* / genetics

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • MicroRNAs